Get the Stockscreener App
32.64
0.74%
0.24
Claritev Corp stock is traded at $32.64, with a volume of 78,815.
It is up +0.74% in the last 24 hours and up +15.17% over the past month.
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
See More
Previous Close:
$32.40
Open:
$32.12
24h Volume:
78,815
Relative Volume:
0.56
Market Cap:
$556.44M
Revenue:
$978.76M
Net Income/Loss:
$-286.52M
P/E Ratio:
-1.8844
EPS:
-17.3212
Net Cash Flow:
$-31.63M
1W Performance:
-5.99%
1M Performance:
+15.17%
6M Performance:
-3.69%
1Y Performance:
-23.20%
1-Day Range:
$31.51
$33.06
1-Week Range:
$31.49
$35.60
52-Week Range:
$11.50
$74.07
Claritev Corp Stock (CTEV) Company Profile
Name
Claritev Corp
Sector
Industry
Phone
212-780-2000
Address
7900 TYSONS ONE PLACE, MCLEAN
Compare CTEV vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTEV
Claritev Corp
|
32.64 | 581.50M | 978.76M | -286.52M | -31.63M | -17.32 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Claritev Corp Stock (CTEV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-24-26 | Initiated | Barclays | Overweight |
| Jan-12-26 | Initiated | Guggenheim | Buy |
| Jan-09-26 | Initiated | Wells Fargo | Equal Weight |
| Oct-21-25 | Upgrade | Citigroup | Neutral → Buy |
| May-29-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-26-24 | Initiated | Piper Sandler | Neutral |
| Dec-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Jul-12-22 | Initiated | Goldman | Neutral |
| Oct-04-21 | Resumed | Citigroup | Buy |
| Apr-07-21 | Initiated | B. Riley Securities | Buy |
| Mar-19-21 | Initiated | Barclays | Equal Weight |
View All
Claritev Corp Stock (CTEV) Latest News
Claritev Corporation(NYSE: CTEV) added to Russell 2000 Value Benchmark - marketscreener.com
Claritev Corporation(NYSE: CTEV) added to Russell Microcap Value Benchmark Index - marketscreener.com
Price to earnings forward of Claritev Corporation – NYSE:CTEV - TradingView
Claritev Corporation(NYSE: CTEV) added to Russell 3000E Value Benchmark - marketscreener.com
Price to sales forward of Claritev Corporation – NYSE:CTEV - TradingView
Enterprise value to EBITDA forward of Claritev Corporation – NYSE:CTEV - TradingView
Enterprise value to revenue forward of Claritev Corporation – NYSE:CTEV - TradingView
Claritev Corp (CTEV) Institutional Confidence - TradingKey
Claritev (CTEV) Stock Faces Mixed Analyst Target Changes As Growth Execution Questions Build - Yahoo Finance
CTEV Forecast — Price Target — Prediction for 2027 - TradingView
Claritev Corporation Class A Actuals & Estimates (NYSE:CTEV) - TradingView
Claritev Can't Use 'Unclean Hands' Defense In Antitrust MDL - Law360
Claritev Says It Wasn't Target Of Criminal Antitrust Probe - Law360
Claritev Corporation Announces Participation in Truist Securities Healthcare Disruptors & Digital Health Conference - Business Wire
CCORF Maintains Claritev(CTEV.US) With Buy Rating, Maintains Target Price $32 - Moomoo
Claritev Corp (CTEV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Claritev Corp (CTEV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Claritev says US DOJ antitrust probe has been closed - MLex
Claritev Cleared of Criminal Probe, Faces Civil Inquiry - TipRanks
DOJ closes Claritev (NYSE: CTEV) antitrust grand jury as civil review continues - Stock Titan
Claritev Corp (CTEV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Claritev Corp (CTEV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Claritev Corp (CTEV) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Claritev Corp (CTEV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Claritev Corp (CTEV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Claritev Corp (CTEV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
The No Surprises Act at a Crossroads: From Protection to Performance - marketscreener.com
Claritev Corporation (CTEV) Q1 2026 Earnings: EPS Misses Estimates, Revenue Unreported, Stock Declines - dars.gov.et
Is Claritev Corp (CTEV) a Bargain After 3.6% Drop? GF Value Says Undervalued - GuruFocus
How The Claritev (CTEV) Investment Story Is Evolving As The Market Holds Its Fair Value View - Yahoo Finance
Insider Buying: Nutter Carol Acquires Shares of Claritev Corp (C - GuruFocus
Claritev SVP Carol Nutter buys $24,856 in company stock By Investing.com - Investing.com Nigeria
Claritev SVP Carol Nutter buys $24,856 in company stock - Investing.com
Claritev (CTEV) chief people officer buys 875 company shares - Stock Titan
Claritev (CTEV) Q1 2026 Earnings Transcript - AOL.com
Piper Sandler Maintains Claritev(CTEV.US) With Buy Rating, Cuts Target Price to $61 - Moomoo
Claritev Cares and Elizabeth Dole Foundation Team Up to Help Military and Veteran Caregivers Navigate Mental Health Benefits - 01net
New free guides help military caregivers untangle mental health insurance - Stock Titan
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
CLARITEV STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating Claritev Corporation on Behalf of Claritev Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corp - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Claritev Corporation (CTEV) And Encourages Shareholders to Connect - ACCESS Newswire
Arizona sues MultiPlan, major insurers, alleging a 'cartel' that underpaid doctors and hospitals - Arizona Mirror
Claritev Q1 2026 Earnings Call Transcript - Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Claritev Corporation (CTEV) and Encourages Shareholders to Learn More About the Investigation | NYSE:CTEV | Press Release - Stockhouse
Claritev (CTEV) Receives Buy Rating and $32 Target from Canaccor - GuruFocus
CTEV Initiated Coverage by Canaccord Genuity -- Rating Set to Bu - GuruFocus
Claritev Corp Stock (CTEV) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.79%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):